NewzA female patient in the Dominican Republic has been waiting one year for a high-cost medication through the Ministry of Public Health's High-Cost Medication Program. The program has reportedly failed to respond to patients requesting admission, leaving individuals dealing with life-threatening illnesses in an uncertain limbo where treatment is their only hope.
The administrative delay highlights systemic vulnerabilities within national health provisions for catastrophic diseases. As applicants await approval and access to critical pharmaceuticals, structural bottlenecks in public healthcare administration continue to jeopardize vulnerable populations.
In-depth summary · AI, neutral